Vicore Pharma Holding AB operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vicore Pharma Holding AB with three other
pharmaceutical manufacturers in Europe:
Elanix Biotechnologies AG
sales of 61,753.00 Euros [US$72,394.89 ]
of which 100%
was Cosmetic ointments),
N4 Pharma PLC
of UNITED KINGDOM
(£72,832.00 [US$94,098.22 ]
(243,000.00 Swedish Kronor [US$27,461.43 ]
During the year ended December of 2018, sales at
Vicore Pharma Holding AB were SEK 508,000.00 (US$57.41 thousand).
decrease of 45.5%
versus 2017, when the company's sales were SEK 932,000.00 .